Colon cancer is cancer of the large intestine (colon), the lower part of your digestive system. Rectal cancer is cancer of the last several inches of the colon. Together, they’re often referred to as colorectal cancers. Our consultant surgeonsare skilled in colon and rectal surgery using advanced surgical techniques to remove cancer, such as minimally invasive surgery.A multidisciplinary team will work with you to review all of your treatment options and choose the treatment that best suits your needs and goals. The range of treatments offered to people with colon cancer includes chemotherapy, radiation, targeted therapy and a variety of operations, including minimally invasive surgery and robotic surgery.

Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern Colorectal surgery  Dubai UAE Sadir Alrawi MD FRCSEd FRCSEng CABS DGS , Best Oncology Team for ColoRectal Surgery, Head & Neck Surgery, Liver & Pancreas Surgery, Melanoma & Sarcoma, HIPEC, Breast Surgery, Lung Surgery, Esophageal & Stomach, Urological Oncology,Thyroid & Parathyroid with Endocrine surgery. Humaid O. Al-Shamsi1,2,3, Jeremy Jones4, Yazan Fahmawi1, Ibrahim Dahbour1, Aziz Tabash1, Reham Abdel-Wahab1,5, Ahmed O. S. Abousamra1, Kenna R. Shaw3, Lianchun Xiao1, Manal M. Hassan1, Benjamin R. Kipp6, Scott Kopetz1, Amr S. Soliman7, Robert R. McWilliams4, Robert A. Wolff1 Journal of Gastrointestinal Oncology. All rights reserved. jgo.amegroups.com J Gastrointest Oncol 2016;7(6):882-902

Humaid O. Al-Shamsi1, Bryan K. Kee1, Michael T. Tetzlaff2, Robert A. Wolff1 Department of Gastrointestinal Medical Oncology, Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, TX 77030, USA Correspondence to: Humaid O. Al-Shamsi. Assistant Professor, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, TX 77030, USA

Thrombotic events in metastatic colorectal cancer patients treated with leucovorin, fluorouracil and irinotican (FOLFIRI) plus bevacizumab Humaid O. Al-Shamsi1,2,3, Abdulaziz Al Farsi1, Mahraz Anjum2, Hua Shen2, Kevin Zbuk1, Richard J. Cook2, Lori-Ann Linkins4, Pierre Major1 1Department of Oncology, McMaster University, Hamilton, Ontario, Canada; 2Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada; 3Department of Medicine, Sheikh Zayed Military Hospital, Abu Dhabi, United Arab Emirates; 4Department of Medicine, McMaster University, Hamilton, Ontario, Canada Correspondence to: Humaid O. Al-Shamsi, MD, FRCPC, FACP. Department of Gastrointestinal Medical Oncology, Unit 426, 1515 Holcombe Blvd, Houston, TX 77030, USA. Email: halshamsi@mdanderson.org. Submitted Jan 29, 2015. Accepted for publication Feb 13, 2015. Breast Surgery Dubai UAE Sadir Alrawi MD FRCSEd FRCSEng, Best Oncology Team for ColoRectal Surgery, Head & Neck Surgery, Liver & Pancreas Surgery, Melanoma & Sarcoma, HIPEC, Breast Surgery, Lung Surgery, Esophageal & Stomach, Urological Oncology, Gynecological Oncology, with American Boarded Medical Oncologists    

A multicentre analysis of abiraterone acetate in Canadian patients with metastatic castration-resistant prostate cancer

Stage III NoneSmall-Cell Lung Cancer: Establishing a Benchmark for the Proportion of Patients Suitable for Radical Treatment

The Current Practice of Screening, Prevention, and Treatment of Androgen-Deprivation-Therapy Induced Osteoporosis in Patients with Prostate Cancer